Stay updated with breaking news from Graphite Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) have received an average recommendation of “Reduce” from the nine ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation and eight have assigned a hold recommendation to the company. The average twelve-month target price among […]
Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the appointment of Alethia Young as its new Chi...
(RTTNews) - Biopharmaceutical company Bicycle Therapeutics plc (BCYC) announced on Friday that it has appointed Alethia Young as its chief financi...
Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) saw a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 672,500 shares, a drop of 11.8% from the May 15th total of 762,400 shares. Based on an average daily volume of 125,900 shares, the days-to-cover ratio is […]
Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 672,500 shares, a drop of 11.8% from the May 15th total of 762,400 shares. Based on an average daily trading volume, of 125,900 shares, the short-interest ratio is presently 5.3 […]